Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Voyager Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Voyager Therapeutics Raises USD60 Million in Series B Financing 12
Voyager Therapeutics Raises US$45 Million In Series A Financing 13
Partnerships 14
Voyager Therapeutics Enters into Agreement with AbbVie Biotechnology 14
Voyager Therapeutics Enters into Research Agreement with CHDI Foundation 16
Voyager Therapeutics Enters into Development Agreement with Genzyme 17
Voyager Therapeutics Enters into Agreement with MassBiologics 18
Licensing Agreements 19
RegenxBio Exercises its Option Agreement with Voyager Therapeutics 19
Voyager Therapeutics Enters into Licensing Agreement with California Institute of Technology 20
Voyager Therapeutics Enters into Licensing Agreement with ReGenX Biosciences 21
Voyager Therapeutics Enters Into Licensing Agreement With University Of Massachusetts 23
Equity Offering 25
Voyager Therapeutics Raises USD62.1 Million in Public Offering of Shares 25
Voyager Therapeutics Plans to Raise up to USD75 Million in Public Offering of Shares 27
Voyager Therapeutics Raises USD80.5 Million in IPO 28
Voyager Therapeutics Raises USD30 million in Private Placement of Series B Preferred Stock 30
Voyager Therapeutics Inc – Key Competitors 31
Voyager Therapeutics Inc – Key Employees 32
Voyager Therapeutics Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Aug 07, 2018: Voyager Therapeutics announces second quarter 2018 financial results and corporate highlights 34
May 10, 2018: Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights 36
Mar 14, 2018: Voyager Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results 38
Nov 02, 2017: Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights 40
Aug 08, 2017: Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights 43
May 09, 2017: Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights 46
Mar 15, 2017: Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights 48
Corporate Communications 51
Jun 28, 2018: Voyager Therapeutics Names Andre Turenne As President And Chief Executive Officer 51
May 29, 2018: Voyager Therapeutics Announces Management Change 53
Jan 31, 2018: Voyager Therapeutics Announces CEO Succession Plan for 2018 54
Sep 18, 2017: Voyager Therapeutics Appoints Matthew P. Ottmer as Chief Operating Officer 55
Jan 05, 2017: Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors 56
Jan 03, 2017: Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer 57
Product News 58
10/16/2018: Voyager Therapeutics announces preclinical data for Amyotrophic Lateral Sclerosis at the Congress of the European Society of Gene and Cell Therapy 58
Jul 17, 2017: Voyager Therapeutics Announces Publication from the California Institute of Technology of a Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the Brain 59
02/13/2017: Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS) 60
Clinical Trials 61
May 17, 2018: Voyager Therapeutics Announces New Data on VY-SOD101 at the American Society of Gene and Cell Therapy 2018 Annual Meeting 61
Appendix 62
Methodology 62
About GlobalData 62
Contact Us 62
Disclaimer 62
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Voyager Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Voyager Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Voyager Therapeutics Raises USD60 Million in Series B Financing 12
Voyager Therapeutics Raises US$45 Million In Series A Financing 13
Voyager Therapeutics Enters into Agreement with AbbVie Biotechnology 14
Voyager Therapeutics Enters into Research Agreement with CHDI Foundation 16
Voyager Therapeutics Enters into Development Agreement with Genzyme 17
Voyager Therapeutics Enters into Agreement with MassBiologics 18
RegenxBio Exercises its Option Agreement with Voyager Therapeutics 19
Voyager Therapeutics Enters into Licensing Agreement with California Institute of Technology 20
Voyager Therapeutics Enters into Licensing Agreement with ReGenX Biosciences 21
Voyager Therapeutics Enters Into Licensing Agreement With University Of Massachusetts 23
Voyager Therapeutics Raises USD62.1 Million in Public Offering of Shares 25
Voyager Therapeutics Plans to Raise up to USD75 Million in Public Offering of Shares 27
Voyager Therapeutics Raises USD80.5 Million in IPO 28
Voyager Therapeutics Raises USD30 million in Private Placement of Series B Preferred Stock 30
Voyager Therapeutics Inc, Key Competitors 31
Voyager Therapeutics Inc, Key Employees 32
Voyager Therapeutics Inc, Subsidiaries 33
List of Figures
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Voyager Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Voyager Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10